MedTrace Logo

Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis

NCT00992888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-09-15

No results posted yet for this study

Summary

The purpose of this study is to investigate the role of endotoxins and the endotoxin mediated immune activation pathway in patients with alcoholic hepatitis. Also, to determine the effect of Liver assist (liver dialyses) intervention on these parameters in patients with severe alcoholic hepatitis.

Conditions

  • Alcoholic Hepatitis

Interventions

DEVICE

Prometheus Liver Dialysis system (Fresenius Medical Care)

6 hour dialysis for 3 consecutive days

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Hendrik Vilstrup, Prof · Department of Medicine V, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00992888 on ClinicalTrials.gov